Results 171 to 180 of about 175,178 (288)

A targeting lentiviral vector for generation of CAR-T cells in vivo. [PDF]

Sci Rep
Tuerxunyiming M, Yin JM, Zhu P, Liu M, Fu Z, Zhao Q.   +5 more
europepmc   +1 more source

Single versus repeated intravenous oncolytic reovirus infusions: Implications for immune modulation and rationalised scheduling of therapy in hepatocellular carcinoma

International Journal of Cancer, EarlyView.
What's New? Oncolytic viruses are a promising immunotherapeutic approach against many malignancies. However, it is unclear whether repeated doses have improved therapeutic value or may trigger greater side effects, especially in patients with hepatocellular carcinoma whose liver is chronically damaged.
Karen J. Scott, Emma J. West, Rebecca J. Brownlie, Fay Ismail, Christy Ralph, Thomas Heineman, Matt Coffey, Alan A. Melcher, Alison Taylor, Salvatore Papa, Adel Samson   +10 more
wiley   +1 more source

Efficacy and immunogenic effects of Tumor Treating Fields (TTFields) in preclinical models of pancreatic ductal adenocarcinoma, with and without gemcitabine/nab‐paclitaxel

International Journal of Cancer, EarlyView.
What's New? Adaptive immune responses are typically limited in pancreatic ductal adenocarcinoma, resulting in minimal efficacy of immune checkpoint inhibitors. Tumor Treating Fields (TTFields) therapy, which uses low‐intensity intermediate‐frequency electric fields to disrupt cancer cell processes, has been approved for certain cancers.
Tal Kan, Tharwat Haj Khalil, Yiftah Barsheshet, Tali Voloshin, Lilach Koren, Bella Koltun, Cfir David, Kerem Wainer‐Katsir, Avital Vorontsova, Boris Brant, Simona Zisman‐Rozen, Hila M. Ene, Roni Frechtel‐Gerzi, Shay Cahal, Anat Klein‐Goldberg, Lena Lifshitz, Efrat Zemer Tov, Mai Shai, Adi Haber, Moshe Giladi, Uri Weinberg, Yoram Palti   +21 more
wiley   +1 more source

CD19 exon 2 skipping is a potential prognostic correlate of anti-CD19 CAR-T therapy relapse. [PDF]

Front Mol Med
Dam SH, Moranzoni G, Høie MH, Modvig S, Wadt KAW, Als-Nielsen B, Schmiegelow K, Vitting-Seerup K, Barnkob MB, Olsen LR.   +9 more
europepmc   +1 more source

The T‐Cell Response Mechanism in Human Papillomavirus‐Associated Cervical Cancer and New Strategies for Immunotherapy

iNew Medicine, EarlyView.
ABSTRACT Human papillomavirus (HPV) is a double‐stranded DNA virus that infects human skin and mucosal tissues exclusively. The German scientist Harald zur Hausen was awarded the 2008 Nobel Prize in Physiology or Medicine for his discovery of the link between HPV infection and cervical cancer.
Fang Zhu, Farah Nazir, Ying Zhou, Yuhua Shang, Hongliang He, Tengchuan Jin   +5 more
wiley   +1 more source

Successful fresh formulation CD19 CAR-T cell therapy for GAD65 antibody-mediated cerebellar ataxia. A Case Report. [PDF]

Front Immunol
Vaisvilas M, Cernauskiene S, Petrosian D, Giedraitiene N, Stoskus M, Griskevicius L.   +5 more
europepmc   +1 more source

STING-associated vasculopathy develops independently of IRF3 in mice [PDF]

, 2017
Ai, Teresa L, Bennion, Brock G, Gonugunta, Vijay K, Irizarry-Caro, Ricardo A, Miner, Cathrine A, Miner, Jonathan J, Platt, Derek J, Sakai, Tomomi, Smith, Amber M, Warner, James D, Wu, Jianjun, Yan, Nan   +11 more
core   +1 more source

Monoclonal Antibody CD19 [PDF]

, 2020
openaire   +1 more source

Flow Cytometric Profiling Reveals Platelet Dysfunction and Impaired Immune Communication in Acute and Chronic Cerebrovascular Disease

Journal of Clinical Laboratory Analysis, EarlyView.
Platelets act as sensors linking inflammation and neurovascular health. Flow cytometry revealed reduced PAC‐1 in acute/subacute ICH but elevated in chronic disease, while P‐selectin remained suppressed. T lymphocyte–platelet aggregates declined across groups, indicating disrupted immune crosstalk, and these biomarkers reflect stage‐specific platelet ...
Chih‐Lung Shen, Li‐Yu Huang, Jhong‐Kuei Chen, Sheng‐Tzung Tsai, Yi‐feng Wu   +4 more
wiley   +1 more source

Tunable CAR-NK-92 activity in the tumor microenvironment via a dual ATF4-responsive circuit. [PDF]

Front Immunol
Manchon E, Hirt N, Soundiramourty A, Versier B, Christen Y, Charron D, Mallet J, Jabrane-Ferrat N, Serguera C, Al-Daccak R.   +9 more
europepmc   +1 more source